DMW - Deutsche Medizinische Wochenschrift, Table of Contents Dtsch Med Wochenschr 2011; 136(33): 1675DOI: 10.1055/s-0031-1281574 Pro & Contra | Commentary Rheumatologie © Georg Thieme Verlag KG Stuttgart · New York Können Biologika bei rheumatoider Arthritis nach Erreichen einer Remission abgesetzt werden? Contra Discontinuation of biologicals in rheumatoid arthritis after acquiring remission? NoM. Grünke1 1Rheumaeinheit, Klinikum der Universität München Recommend Article Abstract Buy Article Schlüsselwörter rheumatoide Arthritis - Biologika - Remission - Erhaltungstherapie Keywords rheumatoid arthritis - biologicals - remission - maintenance therapy Full Text References Literatur 1 Askling J. The risk of malignancies in RA patients treated with biologics. Z Rheumatol. 2010; 69 774-779 2 Braun J, Barraliakos X, Listing J. et al . Persistent clinical efficacy and safety of anti-tumour necrosis factor a therapy with infliximab in patients with ankylosing spondylitis: evidence for different types of response over 5 years. Ann Rheum Dis. 2008; 67 340-345 3 Chatzidionysiou K, van Vollenhoven R F. When to initiate and discontinue biologic treatments for rheumatoid arthritis?. J Intern Med. 2011; 269 614-625 4 Saleem B, Keen H, Goeb V. et al . Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?. Ann Rheum Dis. 2010; 69 1636-1642 5 van den Broek M, Klarenbeek N B, Dirven L. et al . Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Ann Rheum Dis. 2011; 70 1389-1394 Dr. Mathias Grünke OberarztStudienambulanz der RheumaeinheitKlinikum der Universität München Pettenkoferstr. 8a 80336 München Phone: 089 5160 3473 Fax: +49 89 5160 3719 Email: Mathias.Gruenke@med.uni-muenchen.de
